Gennao
PrivateLast Round
Series B
Dec 8, 2022
Total Funding Raised
$56M
Company Overview
Gennao is a biotechnology company focused on developing targeted nucleic acid therapeutics aimed at curing muscle diseases through its innovative gene monoclonal antibody platform technology.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting, Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Gennao Comps
Public and private peers based on sector, stage, and business model.
Gennao Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Dec 8, 2022 | ||||
| Series A Extension | Dec 22, 2021 | ||||
| Series A | May 10, 2021 |
Gennao Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| CureDuchenne Ventures | Series B, Series A Extension |
| GordonMD Global Investments | Series B |
| OrbiMed | Series B, Series A |
| Logos Capital | Series B, Series A |
Gennao Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Gennao's valuation, stock price, and market status.
